Business
The pharma giant’s Digital Health Partnership Program welcomes new innovators in mental health, women’s health and more.
The stock took a tumble in October following the letter.
The life science company plans to launch its open research tool in 2022.
The companies position the acquisition as a way to reduce costs for patients and improve the financial health of provider organizations.
New NHS platform launched to address mental health crisis in young people.
The company is set to debut in the KOSDAQ early next year.
Lindera’s ‘SturzApp’ facilitates motion analysis via an app, using smartphone or tablet cameras to track movement and reduce the risk of falls in seniors.
The pandemic drove the unprecedented funding surge as the healthcare industry swiftly innovated and adopted virtual and hybrid care models.
Polish-based Docplanner steps up expansion plans in Germany.
The firm plans to further develop its blood typing technology.